MASIMO CORPORATION for MASIMO CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Support of Rep. Kuster/Emmer legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Support for Medicare coverage and reimbursement pathway for breakthrough technologies (TCET); Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage and reimbursement and pilot projects.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
| PAUL ORDAL | — |
Copyright/Patent/Trademark CPT
Support for patent reform legislation and proposals; PTAB/judicial ethics; pro-inventor intellectual property policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
Taxation/Internal Revenue Code TAX
Support for R&D tax and SALT cap fix
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
Labor Issues/Antitrust/Workplace LBR
Support for the Open App Markets Act (S 2710) and fair competition
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.